Chronic stress is a widespread health crisis, yet many individuals remain untreated due to financial barriers or the passive nature of existing tracking tools. NEURIVA bridges this gap as an affordable, fully autonomous, closed loop system that not only detects physiological distress but also delivers immediate, non-pharmacological therapy.

To accurately evaluate a user’s biological state, NEURIVA relies on a sophisticated triple modality framework. It fuses real time data from an Electrocardiogram (ECG) to track heart rate variability, a 14 channel Electroencephalogram (EEG) to monitor brainwave oscillations, and a Galvanic Skin Response (GSR) sensor to gauge emotional arousal. This raw physiological data is continuously analyzed by a custom machine learning intelligence layer. Patients can track their long term wellness via a digital dashboard, while a context aware AI chatbox actively monitors their stress probability and proactively initiates cognitive behavioral guidance when anxiety levels rise.

Crucially, NEURIVA closes the loop through active, autonomous treatment. Upon detecting a clinically significant stress event, the system activates a wearable ear electrode to administer Transcutaneous Vagus Nerve Stimulation (tVNS). These gentle electrical pulses stimulate the vagus nerve, which chemically triggers the body’s parasympathetic response and effectively restores physiological calm. Engineered entirely with locally sourced components for under $450, NEURIVA represents a highly accessible and preventative leap in mental health technology.